GTF2A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.26818605301105E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.65829999521483E-08 |
Normal-vs-Stage2 |
5.73949998639023E-09 |
Normal-vs-Stage3 |
4.48197035041176E-13 |
Normal-vs-Stage4 |
1.66033853332692E-12 |
Stage1-vs-Stage2 |
5.927600E-02 |
Stage1-vs-Stage3 |
1.078300E-03 |
Stage1-vs-Stage4 |
1.155760E-04 |
Stage2-vs-Stage3 |
4.026000E-01 |
Stage2-vs-Stage4 |
9.234000E-02 |
Stage3-vs-Stage4 |
3.086200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.78930212260775E-11 |
Normal-vs-AfricanAmerican |
2.06500372357254E-11 |
Normal-vs-Asian |
8.475600E-01 |
Caucasian-vs-AfricanAmerican |
1.337720E-02 |
Caucasian-vs-Asian |
3.156200E-02 |
AfricanAmerican-vs-Asian |
5.956600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.43860487358916E-11 |
Normal-vs-Female |
5.25059995482025E-10 |
Male-vs-Female |
6.641600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.68040000000569E-05 |
Normal-vs-Age(41-60Yrs) |
2.61620003438878E-09 |
Normal-vs-Age(61-80Yrs) |
2.38531416840715E-12 |
Normal-vs-Age(81-100Yrs) |
2.36079999993422E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.942800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.011400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.737200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.803800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.485600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.727570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.600800E-01 |
Normal-vs-Grade 2 |
1.68999999994313E-07 |
Normal-vs-Grade 3 |
2.08969508364021E-11 |
Normal-vs-Grade 4 |
1.62481139653892E-12 |
Grade 1-vs-Grade 2 |
2.192800E-01 |
Grade 1-vs-Grade 3 |
3.996300E-02 |
Grade 1-vs-Grade 4 |
3.441400E-04 |
Grade 2-vs-Grade 3 |
1.467850E-02 |
Grade 2-vs-Grade 4 |
1.74929999996465E-06 |
Grade 3-vs-Grade 4 |
8.235100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.79589000000036E-05 |
Normal-vs-ccB subtype |
1.95189975293886E-10 |
ccA subtype-vs-ccB subtype |
3.437900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.93240004395545E-10 |
Normal-vs-N1 |
1.661679999998E-05 |
N0-vs-N1 |
2.148200E-01 |
|
|